|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.4 TWD | -0.91% |
|
-0.34% | -10.33% |
| May. 06 | Maxigen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 21 | Maxigen Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Maxigen Biotech Inc. announced the appointment of Lin Yung-Hsiang, Liao Sung-Yuan, Li Shi Ming, Zeng Zhong Ming and Chen Ching-Ting to the newly formed risk management committee effective as on May 3, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.33% | 121M | |
| +20.12% | 20.76B | |
| 0.00% | 19.32B | |
| +11.99% | 12.59B | |
| -15.94% | 9.03B | |
| +27.45% | 8.1B | |
| +9.31% | 5.93B | |
| -4.80% | 4.46B | |
| -16.69% | 3.81B | |
| -5.06% | 3.59B |
MAXIGEN BIOTECH INC. 